Related Article from Dual PI3K/mTOR Inhibitors: Does p53 Modulate Response?

dataset

posted on 2023-03-31, 17:14 authored by Oleksandr Ekshyyan, Arunkumar Anandharaj, Cherie-Ann O. Nathan

History

ARTICLE ABSTRACT

Head and neck squamous cell carcinomas have multiple genetic alterations that can influence clinical response to treatment. It is important to evaluate how distinct alterations affect response to targeted agents to identify a subset of patients who can benefit from therapy, improving survival and decreasing toxicity. Clin Cancer Res; 19(14); 3719–21. ©2013 AACR.